| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 04/29/2008 | CA2370098C Human beta-trcp protein |
| 04/29/2008 | CA2285136C Coccidiosis vaccines |
| 04/29/2008 | CA2120353C Cell cycle controlling compositions and methods of using same |
| 04/29/2008 | CA2024487C Polygalacturonase encoding fungal expression system |
| 04/24/2008 | WO2008048407A2 Expression of streptomyces subtilisin inhibitor (ssi) proteins in bacillus and streptomyces sp. |
| 04/24/2008 | WO2008048306A2 Influenza a virus vaccines and inhibitors |
| 04/24/2008 | WO2008047936A1 LYTIC ENZYME INHIBITOR, LYSIS INHIBITOR, INHIBITOR OF DEGRADATION OF POLY-γ-GLUTAMIC ACID, AND METHOD FOR PRODUCTION OF POLY-γ-GLUTAMIC ACID |
| 04/24/2008 | WO2008047925A1 Pharmaceutical composition comprising anti-hb-egf antibody as active ingredient |
| 04/24/2008 | WO2008047914A1 Cancer therapeutic agent comprising anti-hb-egf antibody as active ingredient |
| 04/24/2008 | WO2008047792A1 Crystal of glutathione and process for production thereof |
| 04/24/2008 | WO2008046855A1 Glucanotransferase |
| 04/24/2008 | WO2007084926A3 Compositions and methods for humanization and optimization of n-glycans in plants |
| 04/24/2008 | US20080098490 Recombinant animal for use as bioreactor in production of human immunoglobulins |
| 04/24/2008 | US20080097082 Nucleotide sequences coding recombinant protein for use in prevention and treatment of hyperphosphatemia |
| 04/24/2008 | US20080096981 modulating activities associated with the IL-9 pathway for the treatment of atopic allergies like asthma; autoimmune diseases; new genes tightly expressed in association with an inflammatory response in the airways mediated by type 2 helper T-cells (TH). These genes have been designated TH2AF1 |
| 04/24/2008 | US20080096833 Diagnostic drugs and kits; coded for human proto-oncogene Pim-3, an antibody specific thereto; short interence RNA; genetic engineering |
| 04/24/2008 | US20080096821 Cytostatin II |
| 04/24/2008 | US20080096820 Prodomain modulators of ADAM 10 |
| 04/24/2008 | US20080096819 Amino acid substituted molecules |
| 04/24/2008 | US20080096810 Cab Molecules |
| 04/24/2008 | US20080096796 Peptides That Stimulate Cell Survival and Axon Regeneration |
| 04/24/2008 | US20080096769 Phage displayed trp cage ligands |
| 04/24/2008 | US20080096253 Methods of making nanotechnological and macromolecular biomimetic structures |
| 04/24/2008 | US20080096252 Production of IL-29 from E. coli requires that the aggregated proteins be solubilized from the insoluble inclusion bodies and renatured or refolded; Without renaturation, the specific activity of the recombinant protein will be significantly reduced; higher yields |
| 04/24/2008 | US20080096251 Gonad-stimulating peptide for use in artificial control of starfish populations |
| 04/24/2008 | US20080096250 Expression vector comprising nucleotide sequences coding inflammatory response polypeptide for use in treatment and prevention of inflammation |
| 04/24/2008 | US20080096249 Agarase and gene thereof |
| 04/24/2008 | US20080096248 Grampositive bacterial polypeptide comprising toxin translocation domain for use as therapeutic targeting tools in cosmetic and the treatment of nervous system and nervous system disorders |
| 04/24/2008 | US20080096247 Nucleic acids encoding duramycin |
| 04/24/2008 | US20080096246 Zein-based peptide tags for the expression and purification of bioactive peptides |
| 04/24/2008 | US20080096245 Cystatin-based peptide tags for the expression and purification of bioactive peptides |
| 04/24/2008 | US20080096244 High substrate specificity; vectors, host cells; heat resistance; electrophoresis |
| 04/24/2008 | US20080096243 Using isoeletric focusing and enzymatic digestion to recover glycine max proteins for use as supplements in acidic beverages |
| 04/24/2008 | US20080096239 Orphan Nuclear Receptor |
| 04/24/2008 | US20080096211 Expression vector comprising nucleotide sequences coding stability gene expression or protein secretion/folding (SES) proteins for enhancing production of functional heterologous polypeptides |
| 04/24/2008 | US20080095889 Nucleotide sequences coding enzymatic polypeptide for use in the preparation of bread doughs |
| 04/24/2008 | US20080095833 Immunogens; expression cassettes; gag genes; tat proteins; DNA vaccines; vpr genes; rev genes; envelope genes; antigen presenting cells; liposomes |
| 04/24/2008 | US20080095793 Expression vector comprising nucleotide sequences coding protein fusion for use in treatment and prevention of microorganismal infection |
| 04/24/2008 | US20080095792 Polypeptides For Inducing A Protective Immune Response Against Staphylococcus Aureus |
| 04/24/2008 | US20080095773 Polypeptides homologous to vegf and bmp1 |
| 04/24/2008 | US20080095772 Antibodies against human parathyroid hormone related protein |
| 04/24/2008 | US20080095770 Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof |
| 04/24/2008 | US20080095765 IL-5R-specific antibody composition |
| 04/24/2008 | US20080095762 Glycoprotein compositions |
| 04/24/2008 | US20080095761 Using steroid alkaloid cyclopamine to treat and prevent tumor progression in urogenital system |
| 04/24/2008 | CA2666809A1 Anti-cancer agent comprising anti-hb-egf antibody as active ingredient |
| 04/24/2008 | CA2666559A1 Pharmaceutical composition comprising anti-hb-egf antibody as active ingredient |
| 04/24/2008 | CA2665534A1 Antibodies that bind cxcr7 epitopes |
| 04/24/2008 | CA2665262A1 Method and compositions for stabilizing prostate specific antigen |
| 04/23/2008 | EP1914314A2 Compositions of orthogonal lysyl-tRNA and aminoacyl-tRNA synthetase pairs and uses thereof |
| 04/23/2008 | EP1914312A2 Virulence genes and proteins, and their use |
| 04/23/2008 | EP1914311A1 Extracellular matrix proteins with modified amino acid |
| 04/23/2008 | EP1914310A2 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 04/23/2008 | EP1914301A1 Anti-CD80 antibodies |
| 04/23/2008 | EP1914244A2 Method of modulating the activity of functional immune molecules |
| 04/23/2008 | EP1914243A2 Anti-CD40 monoclonal antibody |
| 04/23/2008 | EP1913149A2 Targeted integration and expression of exogenous nucleic acid sequences |
| 04/23/2008 | EP1699822B1 Il-7 fusion proteins with antibody portions, their preparation and their use |
| 04/23/2008 | EP1687441B1 Means and methods for the determination of camp in vitro |
| 04/23/2008 | EP1462457B1 Cytotoxic protein and utilization thereof |
| 04/23/2008 | EP1422243B1 Humanized antibody against fibroblast growth factor-8 and fragment of the antibody |
| 04/23/2008 | EP1411116B1 Peptide synthase gene, peptide synthase and process for producing dipeptide |
| 04/23/2008 | EP1284993B1 Polypeptides containing polymorphisms of the repeated regions of pertactin in bordetella pertussis, bordetella paraperussis and bordetella bronchiseptica. their use in diagnostics, and in immunogenic compositions |
| 04/23/2008 | EP1182458B1 Method for detecting proteins under mutual interaction |
| 04/23/2008 | EP1109920B1 Fusion proteins useful for measuring protease activity |
| 04/23/2008 | EP1021728B8 Assays, antibodies, and standards for detection of oxidized and mda-modified low density lipoproteins |
| 04/23/2008 | EP0988317B1 Aib1, a steroid receptor co-activator |
| 04/23/2008 | EP0975739B1 Stimulation, culture and preservation of pancreatic and other cells |
| 04/23/2008 | EP0948630B1 Cloning and characterization of napsin, an aspartic protease |
| 04/23/2008 | CN101166823A Combinatorial interleukin-2 muteins |
| 04/23/2008 | CN101166762A Albumin-fused Kunitz domain peptides |
| 04/23/2008 | CN101166757A A novel chimeric polypeptide and use thereof |
| 04/23/2008 | CN101166755A Single chain antibody with cleavable linker |
| 04/23/2008 | CN101165185A Method for producing human interleukins-15 |
| 04/23/2008 | CN101165179A Method for preparing recombination human casein macropeptide |
| 04/23/2008 | CN100383249C Expression method of interleukin 24 from yeast cell |
| 04/23/2008 | CN100383163C Antibody for inhibiting blood coagulation and method of use thereof |
| 04/23/2008 | CN100382842C Orally administered cervus and cucumis polypeptide composition and preparation method thereof |
| 04/22/2008 | US7361740 Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis |
| 04/22/2008 | US7361738 Novel protein factors which share homologous sequences and biological activities with megakaryocyte colony-stimulating factor (meg-CSF); treatment of deficiency of platelets |
| 04/22/2008 | US7361735 Comprises nucleotide sequences coding lipopolysaccharide induced tumor necrosis factor - alpha factor (LITAF) proteins for use in treatment and prevention of cell proliferative disorders; antitumor agents; immunotherapy |
| 04/22/2008 | US7361635 Simultaneous modulation of multiple genes |
| 04/22/2008 | US7361507 Replacing the amino acid in the nitrilase with a cysteine, wherein nitrilase selectivity of the nitrilase NitA of Comamonas testosteroni is modulated |
| 04/22/2008 | US7361495 Polypeptide from a cellulolytic fungus having cellulolytic enhancing activity |
| 04/22/2008 | US7361487 Endoglucanase core region and a heterologous cellulose binding domain; treating cellulosic material, such as textile material, useful in biostoning denim or in biofinishing fabrics and garments; pulp and paper industry, oil extraction from plants, detergents, or for improving the quality of animal feed |
| 04/22/2008 | US7361484 Truncated glycogen synthase kinase 3 crystallizable polypeptide; drug screening for Alzheimer's Disease treatments, antidiabetic and antiinflammatory agents; exposing a GSK3- beta molecule to a putative inhibitor, and measuring the specific enzymatic activity of said GSK3- beta molecule |
| 04/22/2008 | US7361475 Compositions and methods relating to colon specific genes and proteins |
| 04/22/2008 | US7361463 Degradation resistant antihypoxic agents for use in treatment and prevention of hypoxia and ischemic related tissue damage |
| 04/22/2008 | US7361458 Method for producing α-L-aspartyl-L-phenylalanine-β-ester and method for producing α-L-aspartyl-L-phenylalanine-α-methyl ester |
| 04/22/2008 | US7361356 Gene expression in host cell of conformational epitopes; used as elements of diagnostic immunoassay procedures for papillomavirus infection |
| 04/22/2008 | US7361355 Mutant forms of cholera holotoxin as an adjuvant |
| 04/22/2008 | US7361350 Use of an IL-1 antagonist for treating arthritis |
| 04/22/2008 | US7361345 monoclonal antibody prevents the growth or differentiation of the B cell; secreted by the hybridoma; therapy of autoimmune diseases, sytematic lupus erythematosus, primary biliary cirrhosis, and idiopathic thrombocytopenic purpura; biodrug |
| 04/22/2008 | US7361343 Customization of cancer therapy by adminstering modifying antibodies from antigens expressed from cancerous tissue which are cytotoxic to cancer cells while non-toxic to non-cancerous cells; monoclonal antibody antigen binding fragment having identifying characteristics to deposit PTA-4890 at the ATCC |
| 04/22/2008 | US7361342 Cancerous disease modifying antibodies |
| 04/22/2008 | US7361341 Methods of treating cancer using antibodies that immunospecifically bind to trail receptors |
| 04/22/2008 | US7361340 Specifically recognizing human oculospanin and having cytotoxic activity against cancer cells, cancer therapy |
| 04/22/2008 | US7361338 Methods to inhibit growth of prostate cancer cells |
| 04/22/2008 | US7361337 Antibodies against the PRO1754 polypeptides |
| 04/22/2008 | CA2390685C Methods and compositions for inhibiting neoplastic cell growth |